Tag Archives: American depositary shares

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal, Boosting mRNA Oncology Portfolio

(IN BRIEF) BioNTech agreed to buy CureVac in an all-stock deal valuing CureVac at ~$1.25 billion, exchanging each share for $5.46 in BioNTech ADSs—a 55% premium to its recent stock price. The merger, expected to close in 2025, strengthens BioNTech’s … Read the full press release

Credit Suisse Shares to be Delisted Following UBS Acquisition

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules (IN BRIEF) UBS Group AG has announced its acquisition of Credit Suisse Group AG in a deal that is expected to be completed by June 12, … Read the full press release

Syngenta to voluntarily delist its American Depositary Shares from the New York Stock Exchange

BASEL, 29-Dec-2017 — /EuropaWire/ — Following the previously announced cancellation of all publicly held registered shares of Syngenta AG (“Syngenta”) with a par value of CHF 0.10 each in connection with the completion of the public tender offer for all publicly … Read the full press release

Alcatel-Lucent to delist its American depositary shares from the New York Stock Exchange

PARIS, 11-Feb-2016 — /EuropaWire/ — Alcatel-Lucent (the “Company”) announces that its Board of Directors has resolved to voluntarily delist its American depositary shares (“ADSs”), each representing one Alcatel-Lucent ordinary share with a nominal value of EUR 0.05 per share (“Alcatel-Lucent Shares”) … Read the full press release